Skip to main content

Cellectis Gains Access to Japan Tobacco's Genome Modification Technology

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellectis Plant Sciences announced today a licensing agreement giving it access to Japan Tobacco's Agrobacterium transformation technology.

The technology, called PureIntro, will be used by Cellectis Plant Sciences, a subsidiary of Cellectis, to modify corn and rice genomes. Financial terms of the deal were not disclosed.

In a statement, Cellectis Plant Sciences said its technology allows for the insertion, deletion, and modification of gene sequences "to create plants expressing new traits with added value." The PureIntro technology, it added, allows for the efficient delivery of DNA to plant cells.

The technology will allow Cellectis Plant Sciences to modify corn and rice genomes using custom meganucleases.

The Scan

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.